EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives

Francesco Branda iD, Nicola Petrosillo iD, Giancarlo Ceccarelli iD, Marta Giovanetti iD, Andrea De Vito iD, Giordano Madeddu iD, Fabio Scarpa iD, Massimo Ciccozzi iD

Infectious Disease Reports · 01.08.2025 · 17 (4) · 91

DOI: 10.3390/idr17040091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infectious Disease Reports, online erschienen am 01.08.2025. Verfasst von Francesco Branda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive fungal infections (IFIs) represent a growing global health threat, particularly for immunocompromised populations, with mortality exceeding 1.5 million deaths annually. Despite their clinical and economic burden—costing billions in healthcare expenditures—fungal infections remain underprioritized in public health agendas. This review examines the current landscape of antifungal therapy, focusing on advances, challenges, and future directions. Key drug classes (polyenes, azoles, echinocandins, and novel agents) are analyzed for their mechanisms of action, pharmacokinetics, and clinical applications, alongside emerging resistance patterns in pathogens like Candida auris and azole-resistant Aspergillus fumigatus. The rise of resistance, driven by agricultural fungicide use and nosocomial transmission, underscores the need for innovative antifungals, rapid diagnostics, and stewardship programs. Promising developments include next-generation echinocandins (e.g., rezafungin), triterpenoids (ibrexafungerp), and orotomides (olorofim), which target resistant strains and offer improved safety profiles. The review also highlights the critical role of “One Health” strategies to mitigate environmental and clinical resistance. Future success hinges on multidisciplinary collaboration, enhanced surveillance, and accelerated drug development to address unmet needs in antifungal therapy.

Schlagwörter

Stichwörter der Autor:innen

antifungal resistanceantifungal therapydrug developmentemerging fungal threatsfungal pathogensinvasive fungal infectionstherapeutic challenges

Autor:innen und Institutionen

  • Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
  • Infection Prevention & Control/Infectious Disease Service, Fondazione Policlinico Universitario Campus Bio-Medico, 00127 Rome, Italy.
  • Department of Public Health and Infectious Diseases, University of Rome Sapienza, 00185 Rome, Italy.
  • Department of Science and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
  • Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
  • Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.

ORCID-Profile: Francesco Branda, Nicola Petrosillo, Giancarlo Ceccarelli, Marta Giovanetti, Andrea De Vito, Giordano Madeddu, Fabio Scarpa, Massimo Ciccozzi

Zitieren

APA

Branda, F., Petrosillo, N., Ceccarelli, G., Giovanetti, M., De Vito, A., Madeddu, G., Scarpa, F., & Ciccozzi, M. (2025). Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives. Infectious Disease Reports, 17(4), 91. https://doi.org/10.3390/idr17040091

Vancouver

Branda F, Petrosillo N, Ceccarelli G, Giovanetti M, De Vito A, Madeddu G, et al. Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives. Infectious Disease Reports. 2025;17(4):91. doi:10.3390/idr17040091

BibTeX
@article{Branda2025,
  author = {Branda, Francesco and Petrosillo, Nicola and Ceccarelli, Giancarlo and Giovanetti, Marta and De Vito, Andrea and Madeddu, Giordano and Scarpa, Fabio and Ciccozzi, Massimo},
  title = {Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives},
  journal = {Infectious Disease Reports},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {91},
  doi = {10.3390/idr17040091}
}
Kostenlos starten →